An Act to direct the Department of Health to develop a strategic plan for opioid overdose response to reduce rates of drug overdose and drug overdose deaths in the Commonwealth; report.
HB 794 directs the Virginia Department of Health to develop a strategic plan for opioid overdose response aimed at reducing drug overdose rates and overdose deaths in the Commonwealth. The plan must be based on an evaluation and needs assessment of existing opioid overdose prevention, intervention, and treatment efforts in Virginia, so the Department can identify gaps and coordinate a more comprehensive response.
In carrying out this work, the Department must collaborate with the Secretaries of Education, Health and Human Resources, and Public Safety and Homeland Security, along with other state agencies and appropriate stakeholders. The bill also requires the Department to report on the status of the strategic plan and its implementation to the Governor and specified legislative committees by November 1, 2026, and annually thereafter.
The bill does not create a new criminal penalty or direct benefit program, but it does impose a planning and reporting mandate on the Department of Health. It requires state agencies to coordinate on opioid overdose prevention, treatment, and response efforts, and it establishes an ongoing reporting obligation to the executive branch and key legislative committees. The practical effect is to formalize statewide oversight of opioid overdose strategy and to support future policy or funding decisions with a structured assessment of existing services and needs.
The available record shows no committee transcript or recorded vote debate, so there is no documented controversy or opposition in the materials provided. The bill’s enactment as chapter law suggests it moved forward successfully and was treated as a public health response measure. Overall, the measure appears to have been viewed as a constructive, administrative step toward addressing the opioid crisis.
No specific points of contention are reflected in the provided materials. Because there are no transcripts or vote details, it is not possible to identify whether lawmakers disagreed about the scope of the plan, the reporting requirements, agency coordination, or the resources needed to implement the strategy. The bill’s focus on opioid overdose prevention and treatment suggests broad public health support, but the record here does not show any articulated objections.